News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
April, 2025
April 2025
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
282930  
Enfortumab Vedotin Outcomes for Patients with Advanced Urothelial Carcinoma
Bladder Cancer
Dec 24, 2024, 14:29

Enfortumab Vedotin Outcomes for Patients with Advanced Urothelial Carcinoma

Laura Bukavina, Urologic Oncologist at Cleveland Clinic Urology, shared a post on X:

“Advanced urothelial carcinoma patients with TSC1 mutations show higher response rates to EV monotherapy (87% vs. 51%), while presence of CDKN2A/B is neg associated with PFS (4.6 vs. 6 ) mo. (Nectin4 is not available).”

Enfortumab

Genomic Biomarkers Associated with Enfortumab Vedotin Outcomes for Patients with Advanced Urothelial Carcinoma: Analysis of UNITE Study Data

Authors: Tanya Jindal et al.

Enfortumab Vedotin Outcomes for Patients with Advanced Urothelial Carcinoma

advanced urothelial carcinoma Ajjai Alva Ali Raza Khaki. Amanda Nizam Arnab Basu Cameron Pywell cancer Charles Nguyen Christopher Hoimes Cindy Jiang Deepak Kilari Dimitra Bakaloudi Dory Freeman Emily Lemke Hamid Emamekhoo Joaquim Bellmunt Laura Bukavina Matthew Davidsohn Matthew I. Milowsky Matthew T Campbell Mehmet A Bilen Michael Glover Nancy B. Davis Omar Alhalabi OncoDaily Oncology Pedro C Barata Petros Grivas Rafee Talukder Rohit Bose Sean Evans Shilpa Gupta Sumit A. Shah Tanya Jindal Vadim S Koshkin Woogwang Sim Yousef Zakharia
Special Coverage
Blog
Apr 25, 2025, 05:27
Applications are still open for The SIOG Advanced Course 2025
Career
Apr 25, 2025, 04:25
Cary Adams endorses Dato' Dr Saunthari Somasundaram as the candidate for the President-elect for the NCD Alliance
Oncolibrary
Apr 25, 2025, 02:46
FDA Approves Penpulimab for Recurrent or Metastatic Non-Keratinizing Nasopharyngeal Carcinoma
Career
Apr 24, 2025, 21:39
Triparna Sen: I am thrilled and humbled to be nominated as a candidate for the IASLC Board of Directors
Blog
Apr 24, 2025, 21:05
Liz O’Riordan: 25 things I wish I had known before I got breast cancer
Blog
Apr 24, 2025, 20:53
Signing Ceremony of MoU Between Doha University for Science and Technology and Qatar Cancer Society
Blog
Apr 24, 2025, 20:40
Yan Leyfman: How AI is transforming cancer care - from improving diagnosis to reducing disparities
Insight
Apr 24, 2025, 20:28
Fernando Campos: We revealed a harsh Brazilian reality in Sarcoma Study
Insight
Apr 24, 2025, 19:38
George Vlachogiannis: Black patients were less likely to receive nephrectomy compared to non-Hispanic White patients
Blog
Apr 24, 2025, 18:30
Paolo Tarantino: Recent ADCs took a median time of 7 years from clinical introduction to approval
Blog
Apr 24, 2025, 17:56
Milestones from Philippine Cervical Cancer Elimination Operational Plan Workshop - APAC Women's Cancer Coalition
Blog
Apr 24, 2025, 17:55
Julie S. Torode: Attending my first ever AACR conference this week - long over due